| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/10/2000 | CN1252278A Nutriment containing Zn and Ca and beaver meat |
| 05/10/2000 | CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans |
| 05/10/2000 | CN1052163C Composition for curing gallstones and kidney stones |
| 05/10/2000 | CN1052159C Medicinal wine for curing hemorrhoid |
| 05/10/2000 | CN1052157C Soft liver and contracting spleen tablet |
| 05/10/2000 | CN1052154C Material for clearing decayed tooth and tarter removing composition |
| 05/09/2000 | US6060508 Benzylamine derivatives, their preparation and their application in therapeutics |
| 05/09/2000 | US6060504 Administering heat stable crystal form of kappa-opiate agonist asimadoline hydrochloride to treat inflammatory gastrointestinal disorders and simultaneously relieve pain with side effect reduction |
| 05/09/2000 | US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 05/09/2000 | US6060479 Quinazoline-4-one AMPA antagonists |
| 05/09/2000 | US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof |
| 05/09/2000 | US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/09/2000 | US6060460 Use of betaglycan to reduce scarring |
| 05/09/2000 | US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 05/09/2000 | US6060250 Human transferases |
| 05/09/2000 | CA2153584C Cytokine restraining agents |
| 05/09/2000 | CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
| 05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
| 05/09/2000 | CA2019944C Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
| 05/09/2000 | CA1340985C Peptide derivatives |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024907A2 Library of novel "unnatural" natural products |
| 05/04/2000 | WO2000024897A1 Cell surface molecule-induced macrophage activation |
| 05/04/2000 | WO2000024761A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 05/04/2000 | WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 05/04/2000 | WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | WO2000024742A1 Pyrazolopyridine as adenosine antagonists |
| 05/04/2000 | WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers |
| 05/04/2000 | WO2000024724A1 Thiazole-derivatives |
| 05/04/2000 | WO2000024707A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | WO2000024414A1 Preventives/remedies for liver diseases |
| 05/04/2000 | WO2000024407A1 Non-fermented osmotic laxative for treating and preventing colorectal cancers |
| 05/04/2000 | WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | WO2000024388A2 Combination of 5-aminosalicylic acid and a budesonide, 6-methyl prednisolone or prednisolone for treating inflammatory disorders of the intestinal tract |
| 05/04/2000 | WO2000024378A1 Compositions of microspheres for wound healing |
| 05/04/2000 | WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO2000006085A3 Compounds and methods |
| 05/04/2000 | WO1999043672A9 Inhibitors of phospholipase a2 |
| 05/04/2000 | DE19850309A1 Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer Expandable system gastroretensives therapy with prolonged gastric residence |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | DE19849737A1 Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen Combining means for treating inflammatory bowel disease |
| 05/04/2000 | DE19849722A1 Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted phenyl alkenoylguanidine, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/04/2000 | CA2349523A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | CA2348165A1 Dihydropyridine compounds and methods of use |
| 05/04/2000 | CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | CA2347128A1 Library of novel "unnatural" natural products |
| 05/04/2000 | CA2346872A1 Preventives/remedies for liver diseases |
| 05/04/2000 | CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use |
| 05/04/2000 | CA2342626A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/03/2000 | EP0997453A1 Phenoxyisobutyric acid ammonium salts and pharmaceutical formulations containing them |
| 05/03/2000 | EP0996622A1 Novel spiroazabicyclic heterocyclic compounds |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds |
| 05/03/2000 | CN1251995A Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 05/03/2000 | CN1251993A Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 05/03/2000 | CN1251760A Medicine |
| 05/03/2000 | CN1052005C Imidazopyridines and preparation and use thereof as medicines |
| 05/03/2000 | CN1051925C Capsule preparation for pile |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates |
| 05/02/2000 | US6057441 Cardiovascular disorders and gastrointestinal disorders |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase |
| 05/02/2000 | US6057338 Useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057329 Inhibitors of the protein tyrosine kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases |
| 05/02/2000 | US6057321 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056961 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056944 Pharmaceutical compositions for oral use including an NSAID and ceramides |
| 05/02/2000 | US6056930 Synthesis of amorphous calcium phosphate fluoride compounds |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2003009C Method and composition for reducing postsurgical adhesions |
| 04/27/2000 | WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | WO2000023574A2 Hepatitis a vaccines |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023064A1 Treatment of dyspepsia |
| 04/27/2000 | WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release |
| 04/27/2000 | WO2000022937A1 Protein material for slow digestion and its use |
| 04/27/2000 | WO2000006132A3 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |